Michael Petusky
Stock Analyst at Barrington
(3.46)
# 2,367
Out of 4,651 analysts
654
Total ratings
44.3%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XRAY DENTSPLY SIRONA | Maintained: Buy | $17 → $15 | $11.59 | +29.42% | 57 | Aug 10, 2026 | |
| USPH U.S. Physical Therapy | Maintained: Buy | $90 → $98 | $81.24 | +20.63% | 60 | Aug 10, 2026 | |
| HAE Haemonetics | Maintained: Buy | $89 → $95 | $90.80 | +4.63% | 66 | Aug 7, 2026 | |
| LFCR Lifecore Biomedical | Maintained: Buy | $6.5 → $6.25 | $4.72 | +32.42% | 39 | Aug 6, 2026 | |
| LMAT LeMaitre Vascular | Upgraded: Buy | $120 → $95 | $82.38 | +15.32% | 57 | Aug 6, 2026 | |
| OFIX Orthofix Medical | Maintained: Buy | $17 → $14 | $10.34 | +35.40% | 13 | Aug 6, 2026 | |
| BVS Bioventus | Maintained: Buy | $14 → $18 | $14.26 | +26.23% | 7 | Aug 6, 2026 | |
| HSIC Henry Schein | Maintained: Buy | $97 → $104 | $89.77 | +15.85% | 46 | Aug 5, 2026 | |
| MMSI Merit Medical Systems | Maintained: Buy | $107 → $114 | $90.76 | +25.61% | 82 | Jul 31, 2026 | |
| ANIK Anika Therapeutics | Maintained: Buy | $17 → $21 | $21.50 | -2.33% | 50 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $33 | $23.95 | +37.82% | 58 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.38 | - | 54 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1 → $1.5 | $0.6601 | +127.24% | 16 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.015 | n/a | 44 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $58.74 | n/a | 1 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $30 | $25.42 | n/a | 1 | Apr 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6.5 | $1.02 | n/a | 1 | Aug 14, 2013 |
DENTSPLY SIRONA
Aug 10, 2026
Maintained: Buy
Price Target: $17 → $15
Current: $11.59
Upside: +29.42%
U.S. Physical Therapy
Aug 10, 2026
Maintained: Buy
Price Target: $90 → $98
Current: $81.24
Upside: +20.63%
Haemonetics
Aug 7, 2026
Maintained: Buy
Price Target: $89 → $95
Current: $90.80
Upside: +4.63%
Lifecore Biomedical
Aug 6, 2026
Maintained: Buy
Price Target: $6.5 → $6.25
Current: $4.72
Upside: +32.42%
LeMaitre Vascular
Aug 6, 2026
Upgraded: Buy
Price Target: $120 → $95
Current: $82.38
Upside: +15.32%
Orthofix Medical
Aug 6, 2026
Maintained: Buy
Price Target: $17 → $14
Current: $10.34
Upside: +35.40%
Bioventus
Aug 6, 2026
Maintained: Buy
Price Target: $14 → $18
Current: $14.26
Upside: +26.23%
Henry Schein
Aug 5, 2026
Maintained: Buy
Price Target: $97 → $104
Current: $89.77
Upside: +15.85%
Merit Medical Systems
Jul 31, 2026
Maintained: Buy
Price Target: $107 → $114
Current: $90.76
Upside: +25.61%
Anika Therapeutics
Jul 30, 2026
Maintained: Buy
Price Target: $17 → $21
Current: $21.50
Upside: -2.33%
Jul 30, 2026
Maintained: Buy
Price Target: $32 → $33
Current: $23.95
Upside: +37.82%
Jul 28, 2026
Maintained: Hold
Price Target: n/a
Current: $1.38
Upside: -
Jan 6, 2026
Maintained: Buy
Price Target: $1 → $1.5
Current: $0.6601
Upside: +127.24%
May 12, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.015
Upside: n/a
Jun 9, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $58.74
Upside: n/a
Dec 18, 2017
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 25, 2016
Upgraded: Buy
Price Target: $30
Current: $25.42
Upside: n/a
Aug 14, 2013
Rated: Buy
Price Target: $6.5
Current: $1.02
Upside: n/a